Symposium: Innovative techniques in human embryo viability assessmentCan proteomics help to shape the future of human assisted conception?
Section snippets
Mandy Katz-Jaffe is a reproductive geneticist who was awarded her PhD in 2004 from Monash University, Melbourne, Australia. After completing her thesis she moved to the USA to join the research team at the Colorado Center for Reproductive Medicine. Her ongoing research as Genetics Director focuses on the underlying molecular mechanisms associated with embryonic development as well as identifying biomarkers of viability.
References (46)
Predicting human embryo viability: the road to non-invasive analysis of the secretome using metabolic footprinting
Reproductive BioMedicine Online
(2007)- et al.
Assessment of embryo viability: the ability to select a single embryo for transfer – a review
Placenta
(2003) - et al.
Analysis of oocyte physiology to improve cryopreservation procedures
Theriogenology
(2007) - et al.
Noninvasive assessment of human embryo nutrient consumption as a measure of developmental potential
Fertility and Sterility
(2001) - et al.
Embryology in the era of proteomics
Theriogenology
(2007) - et al.
Exposure of mouse oocytes to 1,2-propanediol during slow freezing alters the proteome
Fertility and Sterility
(2008) - et al.
Proteomic analysis of individual human embryos to identify novel biomarkers of development and viability
Fertility and Sterility
(2006) - et al.
Analysis of protein expression (secretome) by human and mouse preimplantation embryos
Fertility and Sterility
(2006) - et al.
Physiological and proteomic approaches to studying prefertilization events in the human
Reproductive BioMedicine Online
(2003) - et al.
Soluble HLA-G release by the human embryo: an interesting artefact?
Reproductive BioMedicine Online
(2006)
The protein profile of mouse mature cumulus–oocyte complex
Biochimica et Biophysica Acta
Soluble HLA-G is absent from human embryo cultures: a reassessment of sHLA-G detection methods
Journal of Reproductive Immunology
sHLA-G production by human IVF embryos: can it be measured reliably?
Journal of Reproductive Immunology
Surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI TOF-MS) and ProteinChip technology in proteomics research
Pathology, Research and Practice
Noninvasive metabolomic profiling of embryo culture media using Raman and near-infrared spectroscopy correlates with reproductive potential of embryos in women undergoing in-vitro fertilization
Fertility and Sterility
Soluble human leukocyte antigen G expression in phase I culture media at 46 h after fertilization predicts pregnancy and implantation from day 3 embryo transfer
Fertility and Sterility
Emerging technology for the molecular study of infertility, and potential clinical applications
Reproductive BioMedicine Online
Increases in phosphorylation of SAPK/JNK and p38MAPK correlate negatively with mouse embryo development after culture in different media
Fertility and Sterility
Proteomic patterns: their potential for disease diagnosis
Molecular and Cellular Endocrinology
Identification of viable embryos in IVF by non-invasive measurement of amino acid turnover
Human Reproduction
Selection based on morphological assessment of oocytes and embryos at different stages of preimplantation development: a review
Human Reproduction Update
Protein patterns of pig oocytes during in-vitro maturation
Biology of Reproduction
Alleviation of the ‘2-cell block’ and development to the blastocyst of CF1 mouse embryos: role of amino acids, EDTA and physical parameters
Human Reproduction
Cited by (0)
Mandy Katz-Jaffe is a reproductive geneticist who was awarded her PhD in 2004 from Monash University, Melbourne, Australia. After completing her thesis she moved to the USA to join the research team at the Colorado Center for Reproductive Medicine. Her ongoing research as Genetics Director focuses on the underlying molecular mechanisms associated with embryonic development as well as identifying biomarkers of viability.
Declaration: The authors report no financial or commercial conflicts of interest.